Induction dose of propofol in patients using cannabis.

Per Flisberg, M J Paech, T Shah, T Ledowski, I Kurowski, R Parsons

Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskriftPeer review

46 Citeringar (SciVal)


BACKGROUND AND OBJECTIVE: An estimated 150 million people worldwide use cannabis. The effect of cannabis on anaesthetic requirements in humans does not appear to have been studied. METHODS: In this prospective, randomized, single-blinded study, 30 male patients using cannabis more than once per week (group C) and 30 nonusers (group NC), aged 18-50 years, were induced with propofol 1.5, 2, 2.5, 3 or 3.5 mg kg. Additional doses were given when required. The primary outcome was the 50% effective dose of propofol and successful induction was determined by loss of consciousness with a bispectral index value of less than 60 and satisfactory insertion of a laryngeal mask. Propofol requirements to achieve these outcomes were recorded. RESULTS: The dose required to achieve the target bispectral index value was not significantly higher in group C, but group C required a significantly higher propofol dose to achieve laryngeal mask insertion (314.0 +/- 109.3 vs. 263.2 +/- 69.5 mg, P < 0.04). The estimated effective propofol induction dose in 50-95% of patients did not significantly differ between groups. CONCLUSION: We conclude that cannabis use increases the propofol dose required for satisfactory clinical induction when inserting a laryngeal mask.
Sidor (från-till)192-195
TidskriftEuropean Journal of Anaesthesiology
StatusPublished - 2009

Ämnesklassifikation (UKÄ)

  • Anestesi och intensivvård


Utforska forskningsämnen för ”Induction dose of propofol in patients using cannabis.”. Tillsammans bildar de ett unikt fingeravtryck.

Citera det här